Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CHPA Looks For FDA Reform Legislation To Deliver Monograph Changes In 2016

This article was originally published in The Tan Sheet

Executive Summary

CHPA chief Scott Melville is optimistic for OTC monograph reform progress in 2016. In an interview about CHPA's 2016 priorities, Melville also said state and local environmental regulations that touch OTC drugs will garner attention.


Related Content

PDUFA Negotiations Begin With FDA Seeking Review System Reform
Unfettered OTC Purchasing With Pre-Tax Savings Tops CHPA Goals In 2015





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts